We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
+10.66%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$5.49B
AUM Growth
+$387M
Cap. Flow
-$101M
Cap. Flow %
-1.83%
Top 10 Hldgs %
34.03%
Holding
100
New
2
Increased
18
Reduced
60
Closed
4

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$28.4M
2
MRNA icon
Moderna
MRNA
+$26.9M
3
OTEX icon
Open Text
OTEX
+$11.4M
4
CAE icon
CAE Inc
CAE
+$8.93M
5
BNS icon
Scotiabank
BNS
+$7.52M

Top Sells

Rank Stock Value
1
CLS icon
Celestica
CLS
+$31.6M
2
SAVE
Spirit Airlines, Inc.
SAVE
+$27.2M
3
T icon
AT&T
T
+$14.2M
4
CNQ icon
Canadian Natural Resources
CNQ
+$13M
5
MFC icon
Manulife Financial
MFC
+$12.8M

Sector Composition

Rank Sector Weight
1 Financials 31.47%
2 Communication Services 16.33%
3 Materials 11.56%
4 Energy 9.5%
5 Healthcare 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HES
51
DELISTED
Hess
HES
$38.2M 0.7%
264,859
-9,038
-3% -$1.32M
FDX icon
52
FedEx
FDX
$73B
$36.6M 0.67%
144,735
-4,220
-3% -$1.07M
SPR
53
DELISTED
Spirit AeroSystems
SPR
$34.4M 0.63%
1,083,410
-16,225
-1% -$398K
FIS icon
54
Fidelity National Information Services
FIS
$19.3B
$33.9M 0.62%
564,055
+3,055
+0.5% +$168K
UPS icon
55
United Parcel Service
UPS
$87.1B
$33.7M 0.61%
214,096
-6,210
-3% -$939K
EFXT
56
Enerflex
EFXT
$2.74B
$32M 0.58%
6,872,836
+9,380
+0.1% +$40.9K
MRNA icon
57
Moderna
MRNA
$57.4B
$31.8M 0.58%
+319,430
New +$26.9M
IVZ icon
58
Invesco
IVZ
$13.6B
$29.8M 0.54%
1,669,663
-43,700
-3% -$630K
CX icon
59
Cemex
CX
$14.7B
$29.2M 0.53%
3,761,746
-1,450
-0% -$9.85K
MRK icon
60
Merck
MRK
$355B
$28.5M 0.52%
261,449
-7,760
-3% -$806K
GPK icon
61
Graphic Packaging
GPK
$2.86B
$27.7M 0.5%
1,123,025
-13,350
-1% -$299K
BIIB icon
62
Biogen
BIIB
$31.9B
$27M 0.49%
104,414
-3,805
-4% -$935K
DKS icon
63
Dick's Sporting Goods
DKS
$11B
$23.8M 0.43%
161,928
-7,278
-4% -$884K
OVV icon
64
Ovintiv
OVV
$18.5B
$21.5M 0.39%
488,357
-60,281
-11% -$2.75M
CPA icon
65
Copa Holdings
CPA
$5.13B
$20.4M 0.37%
192,175
+725
+0.4% +$66.3K
IBN icon
66
ICICI Bank
IBN
$102B
$19.1M 0.35%
799,975
-975
-0.1% -$22.5K
DVN icon
67
Devon Energy
DVN
$56.5B
$17.9M 0.33%
394,165
-5,940
-1% -$272K
BAP icon
68
Credicorp
BAP
$29.6B
$16.8M 0.31%
112,200
+9,000
+9% +$1.17M
VOD icon
69
Vodafone
VOD
$40.9B
$15M 0.27%
1,721,613
-175,543
-9% -$1.6M
PROF
70
Profound Medical
PROF
$208M
$9.46M 0.17%
1,177,850
+13,725
+1% +$130K
FTS icon
71
Fortis
FTS
$27.3B
$8.75M 0.16%
211,703
-700
-0.3% -$28.2K
XBI icon
72
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$5.88M 0.11%
65,800
– –
IIF
73
Morgan Stanley India Investment Fund
IIF
$206M
$4.15M 0.08%
193,375
-21,625
-10% -$480K
YTRA icon
74
Yatra Online
YTRA
$64.6M
$2.57M 0.05%
1,574,120
– –
SCHW
75
Charles Schwab
SCHW
$186B
$1.5M 0.03%
21,846
– –
1 2
3
4

Similar funds

JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return

Letko, Brosseau & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Letko, Brosseau & Associates held 100 positions worth $5.49B, up 7.6% from $5.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Letko, Brosseau & Associates's Q4 2023 filing shows 2 new, 18 increased, 60 reduced and 4 closed positions. Its largest new stake was Moderna: 319,430 shares worth $31.8M. The largest sale was Celestica, an estimated $31.6M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 30% a quarter earlier, followed by Communication Services and Materials.

  • Letko, Brosseau & Associates's largest Q4 2023 buy was Moderna: 319,430 shares worth $31.8M.
  • Letko, Brosseau & Associates added most to Pfizer in Q4 2023, an estimated $28.4M increase.
  • Letko, Brosseau & Associates's biggest Q4 2023 reduction was Celestica, cutting an estimated $31.6M.
  • Letko, Brosseau & Associates fully exited Spirit Airlines, Inc. in Q4 2023, selling an estimated $27.2M.
  • Letko, Brosseau & Associates's ten largest holdings make up 34% of its $5.49B portfolio in Q4 2023.
  • Letko, Brosseau & Associates opened 2 new positions and closed 4 in Q4 2023.
  • Letko, Brosseau & Associates's portfolio value rose 7.6% quarter-over-quarter to $5.49B.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2023, filed 12 Feb 2024.